GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Taiyen Biotech Co Ltd (TPE:1737) » Definitions » Capex-to-Revenue

Taiyen Biotech Co (TPE:1737) Capex-to-Revenue : 0.08 (As of Dec. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Taiyen Biotech Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Taiyen Biotech Co's Capital Expenditure for the three months ended in Dec. 2024 was NT$-64.88 Mil. Its Revenue for the three months ended in Dec. 2024 was NT$782.20 Mil.

Hence, Taiyen Biotech Co's Capex-to-Revenue for the three months ended in Dec. 2024 was 0.08.


Taiyen Biotech Co Capex-to-Revenue Historical Data

The historical data trend for Taiyen Biotech Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiyen Biotech Co Capex-to-Revenue Chart

Taiyen Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 0.10 0.07 0.10 0.10

Taiyen Biotech Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.04 0.14 0.12 0.08

Competitive Comparison of Taiyen Biotech Co's Capex-to-Revenue

For the Household & Personal Products subindustry, Taiyen Biotech Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taiyen Biotech Co's Capex-to-Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Taiyen Biotech Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Taiyen Biotech Co's Capex-to-Revenue falls into.



Taiyen Biotech Co Capex-to-Revenue Calculation

Taiyen Biotech Co's Capex-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-307.61) / 3238.152
=0.09

Taiyen Biotech Co's Capex-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-64.879) / 782.2
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Taiyen Biotech Co  (TPE:1737) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Taiyen Biotech Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Taiyen Biotech Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Taiyen Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 297, Section 1, Chien-Kang Road, South District, Tainan, TWN
Taiyen Biotech Co Ltd operates in personal care and home care products. Its product portfolio comprises beauty care products, health food, skin products, salt products and spices, bottled water, and medical supplies, among others. The group has four reportable segments; Salt products and packaged water department, Biotech cleaning and maintenance department, Construction and services department, and Other departments.. The Salt and Packaged Product Segment accounts for the bulk of revenue. Geographically it operates through the region of Taiwan; however, it also holds a presence in the international market.

Taiyen Biotech Co Headlines

No Headlines